Search Results - Rocío Asensi Diez
- Showing 1 - 2 results of 2
-
1
Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta by Emilio Jesús Alegre del Rey, Rocío Asensi Díez, Juan Carlos García de Paredes Esteban
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book